A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.
Secondary Contact Information
Timing is everything: scientists control rapid re-wiring of brain circuits using patterned visual stimulation
In a new study, published in this week’s issue of the journal Science, researchers show for the first time how the brain re-wires and fine-tunes its connections differently depending on the relative timing of sensory stimuli. In most neuroscience textbooks today, there is a widely held model that explains how nerve circuits might refine their connectivity based on patterned firing of brain cells, but it has not previously been directly observed in real time.
People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation.
Paper by Dr. Eric Latimer published in the April issue of "Clinical Schizophrenia & Related Psychoses"
Underprescribing of Clozapine and Unexplained Variation in Use Across Hospitals and Regions in the Canadian Province of Québec
Clinical guidelines recommend a trial of clozapine for schizophrenia patients who are refractory to other antipsychotics; its benefits for this population, including a reduction in suicide rates, have been documented in numerous studies. This paper uses Québec government administrative data (RAMQ and Med-Echo) to show tha
A study of eye movements in schizophrenia patients provides new evidence of impaired reading fluency in individuals with the mental illness.
We are pleased to present
HENRY NASRALLAH, M.D.
Professor of Psychiatry & Neuroscience,
University of Cincinnati College of Medicine
The title of the presentation is:
THE EVOLVING LANDSCAPE OF NEUROBIOLOGY & PHARMACOTHERAPY IN SCHIZOPHRENIA